类固醇冲洗联合类固醇洗脱鼻窦支架与单用类固醇冲洗在鼻窦术后维持额窦通畅的疗效比较:一项随机对照试验
一项随机对照试验纳入62例伴鼻息肉的慢性鼻窦炎(CRSwNP)患者,每例患者自身对照,随机在一侧额窦放置类固醇洗脱支架,所有患者术后均使用类固醇冲洗。术后24周两组在瘢痕、水肿、通畅度和需额外治疗方面相似;多变量回归显示时间而非支架是瘢痕、通畅度和水肿的独立影响因素。作者认为在持续局部治疗并掌握有效冲洗方法的前提下,类固醇洗脱支架可能不优于单用类固醇冲洗。
要点
- 62例CRSwNP患者自身对照,一侧额窦置入类固醇洗脱支架,所有患者术后均用类固醇冲洗。
- 术后24周两组瘢痕、水肿、通畅度及需额外治疗情况相似(P值分别为0.878、0.688、0.817、1.00、1.00)。
- 多变量回归显示时间为瘢痕(OR=1.32)和通畅度(OR=1.39)的独立危险因素、水肿的独立保护因素(OR=0.40),支架无显著影响。
核心结论
- 对于伴或不伴哮喘、无其他基础系统性疾病因素的CRSwNP患者,在持续局部治疗并掌握有效冲洗方法的前提下,类固醇洗脱支架在减少术后瘢痕和水肿、改善长期额窦通畅或减少额外治疗需求方面可能不优于类固醇冲洗。
研究设计与样本
- 随机对照试验,纳入62例经充分药物治疗失败后接受双侧且程度相等的额窦炎手术的CRSwNP患者,每例患者自身对照,随机将支架置入右侧或左侧额窦。
- 排除标准包括额窦炎程度不等、阿司匹林加重性呼吸系统疾病、囊性纤维化、原发性纤毛运动障碍和免疫受损。
- 所有患者术后均使用类固醇冲洗,在术后1、3、12和24周评估瘢痕、水肿、通畅度和需额外治疗情况,并进行单变量和多变量分析。
主要发现
- 术后24周两组瘢痕、水肿、通畅度和需进一步治疗情况相似(P值分别为0.878、0.688、0.817、1.00和1.00)。
- 类固醇洗脱支架未显著影响上述结局。
临床怎么用
- 作者认为,对于伴或不伴哮喘、无其他基础系统性疾病因素的CRSwNP患者,类固醇洗脱支架在减少术后瘢痕和水肿、改善长期额窦通畅或减少额外治疗需求方面可能不优于类固醇冲洗,前提是患者持续局部治疗并掌握有效冲洗方法。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Steroid rinses and steroid-eluting stents are both options for preventing postoperative stenosis after frontal sinus surgery. This study aimed to assess whether steroid-eluting stents offer added benefit over steroid rinses alone in postoperative healing and long-term frontal sinus patency. METHODS: A randomized controlled trial enrolled patients with CRS with nasal polyps (CRSwNP) who underwent surgery for bilateral and equal frontal sinusitis after failing prior medical therapy. Each patient served as their own control, with each patient randomized to stent placement in either right or left frontal sinuses. Exclusion criteria included unequal frontal sinusitis, aspirin exacerbated respiratory disease, cystic fibrosis, primary ciliary dyskinesia, and immunocompromise. All patients used steroid rinses postoperatively. Scarring, edema, patency, and the need for additional treatments were assessed at 1, 3, 12, and 24 weeks postoperatively. Univariate and multivariate analyses were performed. RESULTS: Sixty-two patients were enrolled. Postoperatively, scarring, edema, patency, and the need for further treatment were similar in both groups at 24 weeks (p = 0.878, 0.688, 0.817, 1.00, and 1.00, respectively). Multivariable regression analysis identified time as an independent risk factor for scarring (OR = 1.32, [1.03‒1.71]) and patency (OR = 1.39, [1.10‒1.82]), while it was an independent protective factor for edema (OR = 0.40, [0.32‒0.49]). The steroid-eluting stent did not significantly affect this. CONCLUSION: For CRSwNP, with or without asthma, without other underlying systemic disease factors, steroid-eluting stents may not add benefit over steroid rinses in reducing postoperative scarring and edema, improving long-term frontal sinus patency, or reducing the need for additional treatments, as long as patients continue topical therapy and know how to rinse effectively.
引用
- Fieux M, Noel J, Roozdar P, et al. Comparing Efficacy of Steroid Irrigation + Steroid-Eluting Sinus Stent Versus Steroid Irrigation Alone for Maintaining Frontal Sinus Patency After Sinus Surgery: A Randomized Controlled Trial. Int Forum Allergy Rhinol. 2025. PMID: 39778085. doi:10.1002/alr.23524
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。